Integra LifeSciences Holdings (IART) — Cash Flow Reinvestment Rate
Integra LifeSciences Holdings (IART) has a Cash Flow Reinvestment Rate of 1.51x as of March 2026, reinvesting $14.85 Million (capex $14.85 Million ) from operating cash flow of $9.80 Million. See how much free cash does Integra LifeSciences Holdings generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Integra LifeSciences Holdings Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Integra LifeSciences Holdings across 26 annual periods. For the full cash flow conversion analysis, see Integra LifeSciences Holdings cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Integra LifeSciences Holdings (1999–2025)
Year-by-year capital reinvestment analysis for Integra LifeSciences Holdings. See Integra LifeSciences Holdings leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.86x | $93.86 Million | $50.38 Million | $81.44 Million | ▼ -51.3% |
| 2024 | 3.83x | $495.23 Million | $129.38 Million | $104.42 Million | ▲ +232.6% |
| 2023 | 1.15x | $161.04 Million | $139.96 Million | $66.86 Million | ▲ +485.3% |
| 2022 | 0.20x | $51.99 Million | $264.47 Million | $47.09 Million | ▲ +27.5% |
| 2021 | 0.15x | $48.16 Million | $312.43 Million | $48.08 Million | ▼ -56.2% |
| 2020 | 0.35x | $71.73 Million | $203.83 Million | $63.89 Million | ▼ -40.5% |
| 2019 | 0.59x | $136.87 Million | $231.43 Million | $134.53 Million | ▲ +50.1% |
| 2018 | 0.39x | $78.65 Million | $199.68 Million | $77.74 Million | ▼ -26.0% |
| 2017 | 0.53x | $60.94 Million | $114.54 Million | $43.50 Million | ▼ -31.2% |
| 2016 | 0.77x | $89.95 Million | $116.41 Million | $47.33 Million | ▲ +45.0% |
| 2015 | 0.53x | $50.36 Million | $94.48 Million | $33.41 Million | ▼ -28.6% |
| 2014 | 0.75x | $59.35 Million | $79.46 Million | $42.40 Million | ▼ -16.9% |
| 2013 | 0.90x | $47.85 Million | $53.27 Million | $47.85 Million | ▼ -26.7% |
| 2012 | 1.23x | $72.00 Million | $58.72 Million | $69.03 Million | ▲ +232.9% |
| 2011 | 0.37x | $38.42 Million | $104.33 Million | $38.42 Million | ▲ +4.7% |
| 2010 | 0.35x | $37.14 Million | $105.57 Million | $37.14 Million | ▲ +82.8% |
| 2009 | 0.19x | $27.57 Million | $143.24 Million | $27.57 Million | ▲ +4.3% |
| 2008 | 0.18x | $13.40 Million | $72.59 Million | $13.40 Million | ▼ -61.5% |
| 2007 | 0.48x | $22.57 Million | $47.03 Million | $22.57 Million | ▲ +198.8% |
| 2006 | 0.16x | $11.52 Million | $71.70 Million | $11.52 Million | ▲ +13.4% |
| 2005 | 0.14x | $8.05 Million | $56.85 Million | $8.05 Million | ▼ -35.1% |
| 2004 | 0.22x | $8.51 Million | $38.98 Million | $8.51 Million | ▲ +97.8% |
| 2003 | 0.11x | $3.84 Million | $34.83 Million | $3.84 Million | ▲ +56.6% |
| 2002 | 0.07x | $2.25 Million | $31.98 Million | $2.25 Million | ▼ -61.3% |
| 2001 | 0.18x | $2.86 Million | $15.70 Million | $2.86 Million | ▼ -97.4% |
| 1999 | 6.92x | $17.30 Million | $2.50 Million | $17.30 Million | — |